SCHEMBL1610220

SCHEMBL1610220

COC(=O)c1nc(C2CC2)nc(N(C)Cc2cccc(OC)c2)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
CHRM3 P20309 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CSF1R P07333 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
CCNA1 P78396 1/20 0.40
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
GBA1 P04062 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12713104 0.92 PDE4B (0.43) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1609602 0.90 PDE4B (0.41) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1609329 0.90 PDE10A (0.41) MTNR1AMTNR1BCHRM3PDE4APDE4B
SCHEMBL12713220 0.89 CSF1R (0.44) KMT2AMEN1CHRM3PDE4APDE4B
SCHEMBL1610446 0.89 NTRK1 (0.41) KMT2AMEN1CHRM3PDE4APDE4B
SCHEMBL1610429 0.88 PDE10A (0.41) MTNR1AMTNR1BKMT2AMEN1CHRM3
SCHEMBL1609907 0.87 ALDH1A1 (0.41) KMT2AMEN1CHRM3PDE4APDE4B
SCHEMBL12713250 0.86 PDE10A (0.40) MTNR1AMTNR1BCHRM3PDE4APDE4B
SCHEMBL1610647 0.86 CSF1R (0.40) KMT2AMEN1CHRM3PDE4APDE4B
SCHEMBL1610432 0.85 TSHR (0.40) KMT2AMEN1CHRM3PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086759-A1 CHEMICAL COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2011-04-14 US disclosed
WO-2009081112-A2 CHEMICAL COMPOUNDS SYNGENTA LIMITED (GB) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086759-A1 CHEMICAL COMPOUNDS DDT, PNPO, CBR3 MTNR1A 2323/4885MTNR1B 2212/4885KMT2A 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.